Nicotinamide Mononucleotide on the European supplement market
Most ingredient pages tell you what Nicotinamide Mononucleotide is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 417 Nicotinamide Mononucleotide products from 113 brands across the EU and US. 42 brands advertise it on Meta right now, and new-ad activity grew 36% in the last 30 days. Germany shows the heaviest advertising, while United States has the largest shelf. The median EU shelf price sits around €59.
New Nicotinamide Mononucleotide ads launched per month on Meta — last 6 months.
How brands use Nicotinamide Mononucleotide, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 29 | 9 | 165 | 6 | €62.47 |
| United Kingdom | 140 | 45 | 9 | 4 | £54.99 |
| France | 10 | 5 | 11 | 1 | €40.00 |
| Italy | 24 | 4 | 8 | 4 | €99.45 |
| Spain | 13 | 5 | 20 | 3 | €34.99 |
| Romania | 29 | 5 | 42 | 2 | 500.00 RON |
| United States | 160 | 33 | 130 | 16 | $76.95 |
| Austria | 0 | 0 | 1 | 1 | — |
Who is on the shelf right now
Top brands by number of Nicotinamide Mononucleotide products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| Nicotinamidă mononucleotidă | 380 |
| Nicotinamid mononucleotid (reduced) | 19 |
| Nicotinamid mononucleotid Liposomal | 8 |
| Nicotinamid mononucleotid (beta) | 5 |
| Nicotinamid mononucleotid (Uthever®) | 2 |
| β-Nicotinamide Mononucleotide Liposomal | 1 |
Regulatory & positioning
| Botanical source | Nicotinamide Mononucleotide |
|---|---|
| Novel food status | Novel food |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | longevity, energy |
No EFSA-authorized health claim exists for Nicotinamide Mononucleotide, yet brands market it for longevity, energy — the gap between claim and positioning is itself a competitive signal.
Where Nicotinamide Mononucleotide shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is Nicotinamide Mononucleotide?
Nicotinamide Mononucleotide (NMN) is a nucleotide derived from ribose and nicotinamide, classified as a vitamin B3 derivative. It is commonly included in dietary supplements aimed at longevity and energy enhancement. NMN is used in formulations targeting cellular metabolism and age-related nutritional support. Its inclusion is often found in products marketed for promoting vitality and metabolic function, appealing to consumers interested in maintaining overall wellness and energy levels.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access